ÖZÇAKIR, H. T. Et Al. 2004. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. Journal of Obstetrics and Gynaecology Research , vol.30, no.2 , 100-104.

ÖZÇAKIR, H. T., Levi, R., Tavmergen, E., & Göker, E. N. T., (2004). Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. Journal of Obstetrics and Gynaecology Research , vol.30, no.2, 100-104.

ÖZÇAKIR, HASAN Et Al. "Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles," Journal of Obstetrics and Gynaecology Research , vol.30, no.2, 100-104, 2004

ÖZÇAKIR, HASAN T. Et Al. "Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles." Journal of Obstetrics and Gynaecology Research , vol.30, no.2, pp.100-104, 2004

ÖZÇAKIR, H. T. Et Al. (2004) . "Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles." Journal of Obstetrics and Gynaecology Research , vol.30, no.2, pp.100-104.

@article{article, author={HASAN TAYFUN ÖZÇAKIR Et Al. }, title={Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles}, journal={Journal of Obstetrics and Gynaecology Research}, year=2004, pages={100-104} }